🔎 Trials Near Me

Akèy › Defisi Antitripsin Alfa-1 › Ohio

Etid klinik pou Defisi Antitripsin Alfa-1 nan Ohio

3 etid pou Defisi Antitripsin Alfa-1 ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 104, Cleveland
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

  • University Hospitals Cleveland Medical Center, Cleveland
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou May 13, 2026 · NCT05677971

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

  • University Hospitals Cleveland Medical Center, Cleveland
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 5, 2026 · NCT06165341

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.